[HTML][HTML] Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo, H Bai, Z Zhang… - BMC cancer, 2020 - Springer
Background The clinical value of combined local radiation and epidermal growth factor
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
[PDF][PDF] Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo, H Bai, Z Zhang… - 2020 - scholar.archive.org
Background: The clinical value of combined local radiation and epidermal growth factor
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
[HTML][HTML] Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo, H Bai, Z Zhang… - BMC Cancer, 2020 - ncbi.nlm.nih.gov
Background The clinical value of combined local radiation and epidermal growth factor
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo, H Bai, Z Zhang… - BMC Cancer, 2020 - go.gale.com
Background The clinical value of combined local radiation and epidermal growth factor
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo, H Bai, Z Zhang… - BMC Cancer, 2020 - europepmc.org
Background The clinical value of combined local radiation and epidermal growth factor
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo, H Bai… - BMC …, 2020 - search.proquest.com
Background The clinical value of combined local radiation and epidermal growth factor
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo, H Bai… - BMC …, 2020 - pubmed.ncbi.nlm.nih.gov
Background The clinical value of combined local radiation and epidermal growth factor
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
Management of medically inoperable and tyrosine kinase inhibitor-naieve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo, H Bai… - BMC Cancer …, 2020 - jglobal.jst.go.jp
Management of medically inoperable and tyrosine kinase inhibitor-naieve early-stage lung
adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional …
adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional …
[HTML][HTML] Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo… - BMC …, 2020 - bmccancer.biomedcentral.com
The clinical value of combined local radiation and epidermal growth factor receptor (EGFR)-
tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve early-stage lung …
tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve early-stage lung …
[PDF][PDF] Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a …
Y Sun, M Wu, M Zhou, X Luo, Y Guo, H Bai, Z Zhang… - 2020 - bmccancer.biomedcentral.com
Background: The clinical value of combined local radiation and epidermal growth factor
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …
receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve …